Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1

Table 2

Association between clinicopathological features and lncRNA H19 expression levels.

Variable	H19 expression level
	Higher	Lower
Patients
34	17	17
Mitotic rate: n (%)
<5/50 HPF: 9	6	3
≥5/50 HPF: 11	4	7
Tumor size: n (%)
<5 cm: 12	6	6
≥5 cm: 8	4	4
Tumor site
Stomach/small intestine: 22	11	11
Colon-rectum: 2	2	0
Risk classification (Miettinen’s criteria)
Low risk/very low risk: 7	5	2
Intermediate/high risk: 7	4	3
Onset
Localized: 24	11	13
Metastatic: 10	6	4
Mutation analysis
Wild-type: 7	4	3
Mutated: 21	10	11